Short answer
Replimune Group, Inc. (REPL) filed an 8-K current report with the SEC on September 16, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 5.07 (Submission of Matters to a Vote of Security Holders). Common-stock authorization doubled from 150 million to 300 million shares.
Replimune Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Common-stock authorization doubled from 150 million to 300 million shares
- Stockholders approved the amendment at the September 15, 2026 annual meeting
- Delaware filing made the amendment effective immediately
- Expanded authorization increases future equity-financing capacity and potential dilution risk for existing holders
Item 5.07 · Submission of Matters to a Vote of Security Holders
- PwC ratified as independent auditor for fiscal year ending March 31, 2027, with 63,434,745 votes in favor
- Executive compensation approved advisory basis, with 48,641,528 votes for and 14,440,328 broker non-votes
- Authorized common shares doubled from 150,000,000 to 300,000,000
- Share increase approved by 62,153,709 votes, expanding potential financing and dilution capacity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Replimune Group, Inc. 8-K filings
Get the next REPL 8-K as it lands
Follow REPL for push alerts, or ask the research agent what this filing means.